Drug Topics September 26, 2024
Check out this list of our top 10 stories from September 2024.
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
The FDA granted clearance to the digital therapeutic DaylightRX for the treatment of generalized anxiety disorder (GAD) as an adjunct to usual care in patients aged 22 years and older. The therapy is the first digital treatment approved to treat GAD in the United States.
FDA Approves Updated Novavax COVID-19 Vaccine
The FDA has granted emergency use authorization (EUA) to an updated COVID-19 vaccine from Novavax to prevent the disease in individuals aged 12 years and older. The protein-based vaccine, called NVX-CoV2705, is an updated 2024-2025 formula that includes a monovalent component corresponding to the Omicron variant...
Today's Sponsors
Today's Sponsor